UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 46

Sortiert nach

Severe Neurological Toxicity of Immune Checkpoint Inhibitors: Growing Spectrum

Annals of neurology, 2020-05, Vol.87 (5), p.659-669

2020

Volltextzugriff (PDF)

The Incidence, Causes, and Risk Factors of Acute Kidney Injury in Patients Receiving Immune Checkpoint Inhibitors

Clinical journal of the American Society of Nephrology, 2019-12, Vol.14 (12), p.1692-1700

2019

Volltextzugriff (PDF)

Effect of the Opioid Crisis on the Donor Pool for Kidney Transplantation: An Analysis of National Kidney Deceased Donor Trends from 2010–2016

American journal of nephrology, 2018-01, Vol.47 (2), p.84-93

2018

Volltextzugriff (PDF)

Direct-acting antiviral therapy for hepatitis C virus infection in the kidney transplant recipient

Kidney international, 2018-03, Vol.93 (3), p.560-567

2018

Volltextzugriff (PDF)

Varied phenotypes and management of immune checkpoint inhibitor-associated neuropathies

Neurology, 2019-09, Vol.93 (11), p.e1093

2019

Volltextzugriff (PDF)

Hyponatremia and other electrolyte abnormalities in patients receiving immune checkpoint inhibitors

Nephrology, dialysis, transplantation, 2021-12, Vol.36 (12), p.2241-2247

2021

Volltextzugriff (PDF)

Direct-acting antiviral therapy slows kidney function decline in patients with Hepatitis C virus infection and chronic kidney disease

Kidney international, 2020-01, Vol.97 (1), p.193-201

2020

Volltextzugriff (PDF)

Incidence and Predictors of CKD and Estimated GFR Decline in Patients Receiving Immune Checkpoint Inhibitors

American journal of kidney diseases, 2022-01, Vol.79 (1), p.134-137

2022

Volltextzugriff (PDF)

Efficacy and Safety of Direct Acting Antivirals in Kidney Transplant Recipients with Chronic Hepatitis C Virus Infection

PloS one, 2016-07, Vol.11 (7), p.e0158431-e0158431

2016

Volltextzugriff (PDF)

Effect of Sofosbuvir-Based Hepatitis C Virus Therapy on Kidney Function in Patients with CKD

Clinical journal of the American Society of Nephrology, 2017-10, Vol.12 (10), p.1615-1623

2017

Volltextzugriff (PDF)

Immune-related adverse events and kidney function decline in patients with genitourinary cancers treated with immune checkpoint inhibitors

European journal of cancer (1990), 2021-11, Vol.157, p.50-58

2021

Volltextzugriff (PDF)

Clinical features of acute kidney injury in patients receiving dabrafenib and trametinib

Nephrology, dialysis, transplantation, 2022-02, Vol.37 (3), p.507-514

2022

Volltextzugriff (PDF)

Incidence and Clinical Features of Immune-Related Acute Kidney Injury in Patients Receiving Programmed Cell Death Ligand-1 Inhibitors

Kidney international reports, 2020-10, Vol.5 (10), p.1700-1705

2020

Volltextzugriff (PDF)

Evaluation of appendectomy as a potential risk factor for immune checkpoint inhibitor-associated enterocolitis

Immunotherapy, 2023-08, Vol.15 (12), p.913-920

2023

Volltextzugriff (PDF)

When and how can nephrologists treat hepatitis C virus infection in dialysis patients?

Seminars in dialysis, 2018-01, Vol.31 (1), p.26-36

2018

Volltextzugriff (PDF)

Diagnostic utility of CT for suspected immune checkpoint inhibitor enterocolitis

Journal for immunotherapy of cancer, 2020-10, Vol.8 (2), p.e001329

2020

Volltextzugriff (PDF)

Process of selecting and educating HCV‐uninfected kidney waiting‐list candidates for HCV‐infected kidney transplantation

Artificial organs, 2019-09, Vol.43 (9), p.913-920

2019

Volltextzugriff (PDF)

Preemptive Treatment With Elbasvir and Grazoprevir for Hepatitis C–Viremic Donor to Uninfected Recipient Kidney Transplantation

Kidney international reports, 2020-04, Vol.5 (4), p.459-467

2020

Volltextzugriff (PDF)

Transplantation of hepatitis C virus infected kidneys into hepatitis C virus uninfected recipients

Hemodialysis international, 2018-04, Vol.22 (S1), p.S71-S80

2018

Volltextzugriff (PDF)

Acute Kidney Injury Following Encorafenib and Binimetinib for Metastatic Melanoma

Kidney medicine, 2020-05, Vol.2 (3), p.373-375

2020

Volltextzugriff (PDF)

Low Complement C4 Predicts Improvement of Kidney Function After Direct‐Acting Antiviral Therapy for Hepatitis C Virus

Hepatology communications, 2020-08, Vol.4 (8), p.1206-1217

2020

Volltextzugriff (PDF)

Lupus-like Immune Complex-mediated Glomerulonephritis in Patients with Hepatitis C Virus Infection Treated with Oral, Interferon-free, Direct-acting Antiviral Therapy

Kidney international reports, 2016-09, Vol.1 (3), p.135-143

2016

Volltextzugriff (PDF)

A Risk Prediction Model for Contrast-Associated Acute Kidney Injury (CA-AKI): SA-PO146

Journal of the American Society of Nephrology, 2022-11, Vol.33 (11S), p.642-642

2022

Volltextzugriff (PDF)

Safety and Efficacy of Immune Checkpoint Inhibitors in Patients on Dialysis: A Retrospective Case Series

American journal of kidney diseases, 2020-08, Vol.76 (2), p.299-302

2020

Volltextzugriff (PDF)

1 – 25 von 46

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(40)
Mit Volltextzugriff
(40)

Publikationsform

Sprache

Englisch
(45)
Japanisch
(6)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

Severe Neurological Toxicity of Immune Checkpoint Inhibitors: Growing Spectrum

The Incidence, Causes, and Risk Factors of Acute Kidney Injury in Patients Receiving Immune Checkpoint Inhibitors

Effect of the Opioid Crisis on the Donor Pool for Kidney Transplantation: An Analysis of National Kidney Deceased Donor Trends from 2010–2016

Direct-acting antiviral therapy for hepatitis C virus infection in the kidney transplant recipient

Varied phenotypes and management of immune checkpoint inhibitor-associated neuropathies

Hyponatremia and other electrolyte abnormalities in patients receiving immune checkpoint inhibitors

Direct-acting antiviral therapy slows kidney function decline in patients with Hepatitis C virus infection and chronic kidney disease

Incidence and Predictors of CKD and Estimated GFR Decline in Patients Receiving Immune Checkpoint Inhibitors

Efficacy and Safety of Direct Acting Antivirals in Kidney Transplant Recipients with Chronic Hepatitis C Virus Infection

Effect of Sofosbuvir-Based Hepatitis C Virus Therapy on Kidney Function in Patients with CKD

Immune-related adverse events and kidney function decline in patients with genitourinary cancers treated with immune checkpoint inhibitors

Clinical features of acute kidney injury in patients receiving dabrafenib and trametinib

Derivation and external validation of a simple risk score for predicting severe acute kidney injury after intravenous cisplatin: cohort study

Incidence and Clinical Features of Immune-Related Acute Kidney Injury in Patients Receiving Programmed Cell Death Ligand-1 Inhibitors

Evaluation of appendectomy as a potential risk factor for immune checkpoint inhibitor-associated enterocolitis

When and how can nephrologists treat hepatitis C virus infection in dialysis patients?

Diagnostic utility of CT for suspected immune checkpoint inhibitor enterocolitis

Process of selecting and educating HCV‐uninfected kidney waiting‐list candidates for HCV‐infected kidney transplantation

Preemptive Treatment With Elbasvir and Grazoprevir for Hepatitis C–Viremic Donor to Uninfected Recipient Kidney Transplantation

Transplantation of hepatitis C virus infected kidneys into hepatitis C virus uninfected recipients

Acute Kidney Injury Following Encorafenib and Binimetinib for Metastatic Melanoma

Low Complement C4 Predicts Improvement of Kidney Function After Direct‐Acting Antiviral Therapy for Hepatitis C Virus

Lupus-like Immune Complex-mediated Glomerulonephritis in Patients with Hepatitis C Virus Infection Treated with Oral, Interferon-free, Direct-acting Antiviral Therapy

A Risk Prediction Model for Contrast-Associated Acute Kidney Injury (CA-AKI): SA-PO146

Safety and Efficacy of Immune Checkpoint Inhibitors in Patients on Dialysis: A Retrospective Case Series

Suchergebnisse filtern